Yi Ta Lue
Net worth: - $ as of 31/08/2026
Net worth: - $ as of 31/08/2026
Yi Ta Lue is currently an Independent Director at Belite Bio, Inc. since 2022.
Former positions include Director at EirGenix, Inc., Investment Manager at Capital Realm Financial Holdings Group Ltd. from 2006 to 2008, Investment Manager at CDIB Capital Group from 2001 to 2006, Head-Greater China Healthcare at KGI Securities Co., Ltd. from 2009 to 2017, Investment Manager at CIDC Consultants, Inc., Analyst at KGI Securities Investment Advisory Co., Ltd., Research Associate at MedImmune LLC from 1999 to 2001, and VP-Business Development & Investor Relations at PT Etana Biotechnologies Indonesia from 2017 to 2018.
Education includes graduate studies at The Johns Hopkins University and undergraduate studies at the University of Illinois At Urbana–Champaign.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BELITE BIO, INC. -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| BELITE BIO, INC | Director/Board Member | 01/04/2022 |
| Companies | Position | End |
|---|---|---|
PT Etana Biotechnologies Indonesia
PT Etana Biotechnologies Indonesia Pharmaceuticals: MajorHealth Technology Produces biopharmaceuticals | Investor Relations Contact | 01/01/2018 |
KGI Securities Co., Ltd.
KGI Securities Co., Ltd. Investment Banks/BrokersFinance Provides securities brokerage, underwriting and voluntary trading services | Corporate Officer/Principal | 01/01/2017 |
CIDC Consultants, Inc.
CIDC Consultants, Inc. Investment ManagersFinance CIDC Consultants is an active manager which invests in companies in the biotech (drug development, diagnostic kits, health care, advanced technology) and electronics/IT (IC design, wireless communications, broadband communications, online multimedia content, microelectromechanical devices, nanotechnology) sectors in Taiwan and internationally. The firm makes direct and indirect investments in companies, aiming to create value for shareholders and for the investee company. They partner with their affiliates to leverage their capital, business relationships, industry expertise and information network and invite their investment partners or shareholders to participate in the investment by taking significant ownership positions in their investee companies. When investee companies and shareholders or affiliated companies have an upstream/downstream relationship or have complementary business strategies or resources, CIDC Consultants aims to achieve mutual advantage for all parties, assisting them to achieve resource integration or to jointly pursue strategic projects. The firm utilizes relationships with foreign partners to incubate new projects, introduce new technologies, new products and business approaches suited to Taiwan's development. | Private Equity Investor | 01/01/2008 |
| CAPITAL REALM FINANCIAL HOLDINGS GROUP LIMITED | Chief Investment Officer | 01/01/2008 |
CDIB Capital Group
CDIB Capital Group Investment ManagersFinance Operates as a private equity firm | Corporate Officer/Principal | 01/01/2006 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Capital Realm Financial Holdings Group Ltd.
Capital Realm Financial Holdings Group Ltd. Financial ConglomeratesFinance Operates as an investment holding company with interest in the investment of securities | Finance |
CDIB Capital Group
CDIB Capital Group Investment ManagersFinance Operates as a private equity firm | Finance |
KGI Securities Co., Ltd.
KGI Securities Co., Ltd. Investment Banks/BrokersFinance Provides securities brokerage, underwriting and voluntary trading services | Finance |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CIDC Consultants, Inc.
CIDC Consultants, Inc. Investment ManagersFinance CIDC Consultants is an active manager which invests in companies in the biotech (drug development, diagnostic kits, health care, advanced technology) and electronics/IT (IC design, wireless communications, broadband communications, online multimedia content, microelectromechanical devices, nanotechnology) sectors in Taiwan and internationally. The firm makes direct and indirect investments in companies, aiming to create value for shareholders and for the investee company. They partner with their affiliates to leverage their capital, business relationships, industry expertise and information network and invite their investment partners or shareholders to participate in the investment by taking significant ownership positions in their investee companies. When investee companies and shareholders or affiliated companies have an upstream/downstream relationship or have complementary business strategies or resources, CIDC Consultants aims to achieve mutual advantage for all parties, assisting them to achieve resource integration or to jointly pursue strategic projects. The firm utilizes relationships with foreign partners to incubate new projects, introduce new technologies, new products and business approaches suited to Taiwan's development. | Finance |
KGI Securities Investment Advisory Co., Ltd.
KGI Securities Investment Advisory Co., Ltd. Investment ManagersFinance Provides investment research | Finance |
EirGenix, Inc.
EirGenix, Inc. BiotechnologyHealth Technology Provides biotechnology research and development services | Health Technology |
PT Etana Biotechnologies Indonesia
PT Etana Biotechnologies Indonesia Pharmaceuticals: MajorHealth Technology Produces biopharmaceuticals | Health Technology |
University of Illinois At Urbana–Champaign
University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Belite Bio, Inc.
Belite Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical drug development company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions